Johnson & Johnson (JNJ)

• Market cap: $392B
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

18% more call options, than puts

Call options by funds: $2.11B | Put options by funds: $1.78B

9.17% more ownership

Funds ownership: 61.81% [Q1] → 70.97% (+9.17%) [Q2]

1% less funds holding

Funds holding: 3,759 [Q1] → 3,707 (-52) [Q2]

7% less capital invested

Capital invested by funds: $268B [Q1] → $251B (-$17.7B) [Q2]

16% less repeat investments, than reductions

Existing positions increased: 1,467 | Existing positions reduced: 1,753

19% less funds holding in top 10

Funds holding in top 10: 202 [Q1] → 163 (-39) [Q2]

25% less first-time investments, than exits

New positions opened: 158 | Existing positions closed: 210

Research analyst outlook

18 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $150 8% downside
• Avg. target: $196 21% upside
• High target: $215 32% upside

18 analyst ratings

• positive: 15 83%
• neutral: 3 17%
• negative: 0 0%

Citigroup Joanne Wuensch 74% 1-year accuracy 20 / 27 met price target	14% upside $185	Buy Maintained	16 Oct 2024
Wells Fargo Larry Biegelsen 63% 1-year accuracy 22 / 35 met price target	2% upside $166	Equal-Weight Maintained	16 Oct 2024
Cantor Fitzgerald Louise Chen 56% 1-year accuracy 69 / 124 met price target	32% upside $215	Overweight Reiterated	16 Oct 2024
RBC Capital Shagun Singh 76% 1-year accuracy 44 / 58 met price target	11% upside $181	Outperform Maintained	16 Oct 2024
Morgan Stanley Terence Flynn 47% 1-year accuracy 7 / 15 met price target	7% upside $175	Equal-Weight Maintained	16 Oct 2024